system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Adult, Cell Line, Tumor, Female, Gene Expression Regulation, Neoplastic, Genetic Predisposition to Disease, HeLa Cells, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, RNA, Messenger, Reverse Transcriptase Polymerase Chain Reaction, Snail Family Transcription Factors, Transcription Factors, Uterine Cervical Neoplasms.
user
Is [ Expression of SNAIL mRNA in uterine cervical cancer detected by real-time PCR ]? Context: To investigate the expression pattern and significance of zinc-finger transcription factor SNAIL on transcriptional level, which expressed in human cervical cancer tissues and cell lines. With using real-time PCR, the expression of mRNA for SNAIL was studied in 5 cervical cancer in situ, 55 invasive cervical cancers, 14 normal cervical tissues and 3 cervical cancer cell lines including HeLa, SiHa and C33A. A analysis was made for the relationship between changes of SNAIL mRNA expression and different clinicopathologic parameters of invasive cervical cancer. The level of SNAIL mRNA expression in normal cervical tissues, cervical cancers in situ and invasive cancers was 0. 01+/- 0. 01, 0. 08 +/- 0. 05 or 0. 09 +/- 0. 07, respectively. The expression of SNAIL was higher in cervical cancer in situ and invasive cervical cancer than in normal cervical tissue (P < 0.05). There was no evident change of SNAIL mRNA expression among different FIGO stage, histological differentiation, invasion depth and lymph node metastasis state. SNAIL mRNA expression in SiHa cell line was significantly higher than that in HeLa and C33A cell lines (0.18 +/- 0.05, 0.06 +/- 0.06 and 0.09 +/- 0.08, respectively, P < 0.05).
assistant
SNAIL is probably associated with the initiation and progression of cervical cancer and seems to be a promising candidate marker in early stage cervical cancer. Final Decision: yes